Snowflake Score | |
---|---|
Valuation | 1/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 6/6 |
Dividends | 0/6 |
Orphazyme A/S Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | kr.158.00 |
52 Week High | kr.457.50 |
52 Week Low | kr.84.80 |
Beta | 0.17 |
1 Month Change | 0.64% |
3 Month Change | -0.32% |
1 Year Change | 79.95% |
3 Year Change | -97.82% |
5 Year Change | -97.57% |
Change since IPO | -97.43% |
Recent News & Updates
Recent updates
Shareholder Returns
1TB0 | DE Biotechs | DE Market | |
---|---|---|---|
7D | 0% | 2.8% | 1.3% |
1Y | 80.0% | 35.3% | 6.4% |
Return vs Industry: 1TB0 exceeded the German Biotechs industry which returned 35.3% over the past year.
Return vs Market: 1TB0 exceeded the German Market which returned 6.4% over the past year.
Price Volatility
1TB0 volatility | |
---|---|
1TB0 Average Weekly Movement | 10.8% |
Biotechs Industry Average Movement | 5.8% |
Market Average Movement | 4.8% |
10% most volatile stocks in DE Market | 10.2% |
10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: 1TB0 has not had significant price volatility in the past 3 months.
Volatility Over Time: 1TB0's weekly volatility has decreased from 22% to 11% over the past year, but is still higher than 75% of German stocks.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2009 | 1 | n/a | https://www.orphazyme.com |
Orphazyme A/S does not have significant operations. Previously, the company was engaged in the development of therapies for the treatment of neurodegenerative rare diseases. The company was incorporated in 2009 and is headquartered in Copenhagen, Denmark.
Orphazyme A/S Fundamentals Summary
1TB0 fundamental statistics | |
---|---|
Market cap | €5.63m |
Earnings (TTM) | -€3.57m |
Revenue (TTM) | n/a |
0.0x
P/S Ratio-1.6x
P/E RatioIs 1TB0 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
1TB0 income statement (TTM) | |
---|---|
Revenue | kr.0 |
Cost of Revenue | kr.0 |
Gross Profit | kr.0 |
Other Expenses | kr.26.65m |
Earnings | -kr.26.65m |
Last Reported Earnings
Jun 30, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | -754.70 |
Gross Margin | 0.00% |
Net Profit Margin | 0.00% |
Debt/Equity Ratio | 0% |
How did 1TB0 perform over the long term?
See historical performance and comparison